Generic Name (Trade Name—Company)
Notes
February 21, 2012
Cytarabine
(No trade name—Bedford Laboratories)
Sterility risk prompts recall
Bedford Laboratories announced a nationwide voluntary recall of three lots of cytarabine for injection 1 g/vial (NDC #55390-133-01) because of a potential elevated risk of a lack of sterility assurance for these specific lots. An investigation of the manufacturing area resulted in this recall announcement. The affected lot numbers are 2066986 (expiration date March 31, 2014), 2111675 (expiration date April 30, 2014), and 2131148 (expiration date May 31, 2014).
As of today, there have been no reports of any adverse events associated with the specific lots being recalled. Health care providers with questions concerning the use of the product are instructed to contact Bedford's Client Services Department at 800-562-4797.
